Washington University School of Medicine in St. Louis and pharmaceutical company Eisai Co. Ltd. have formed a research collaboration aimed at developing new treatments for Alzheimer’s disease and other neurodegenerative conditions.
WashU, Eisai form drug discovery collaboration – Washington University School of Medicine in St. Louis wustl.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wustl.edu Daily Mail and Mail on Sunday newspapers.
Memory loss is often the first sign of Alzheimer's disease, followed by confusion and difficulty thinking. These symptoms reflect the typical pattern of worsening damage to brain tissues. Toxic clusters of proteins first concentrate in the temporal lobes of the brain -; the memory area -; before spreading to parts of the brain important for thinking and planning.
Memory loss is frequently the first symptom of Alzheimer's disease, followed by confusion and difficulties in thinking. These symptoms are characteristic of progressive brain tissue destruction. Toxic protein clusters first concentrate in the temporal lobes of the brain, the memory area, before spre
New clues to why Alzheimer's damages parts of the brain scienceblog.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scienceblog.com Daily Mail and Mail on Sunday newspapers.